IL-6 levels returned to baseline levels at 72 h post-infusion, except for in one patient with pancreatic cancer in the 2.0 mg/kg cohort in which IL-6 levels remained elevated until C1D15 (Fig. 3D). The gene discussed is IL6; the disease is familial pancreatic carcinoma.